138 related articles for article (PubMed ID: 6803556)
1. Effects of beta-adrenergic blockade with pindolol versus placebo in coronary patients with stable angina pectoris.
Dwyer EM; Pepe AJ; Pinkernell BH
Am Heart J; 1982 May; 103(5):830-3. PubMed ID: 6803556
[TBL] [Abstract][Full Text] [Related]
2. Variability of response to beta receptor blockade for angina pectoris in clinical trials: a study of pindolol.
Harston WE; Friesinger GC
Am J Cardiol; 1982 Oct; 50(4):722-7. PubMed ID: 6127028
[TBL] [Abstract][Full Text] [Related]
3. Randomized double-blind study of pindolol in patients with stable angina pectoris.
Harston WE; Friesinger GC
Am Heart J; 1982 Aug; 104(2 Pt 2):504-11. PubMed ID: 7102537
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravenous and oral pindolol on exercise tolerance and electrocardiographic changes in angina pectoris.
Storstein L
J Cardiovasc Pharmacol; 1980; 2(6):739-50. PubMed ID: 6160324
[TBL] [Abstract][Full Text] [Related]
5. [Beta-blockader, pindolol, in the therapy of angina pectoris; a report on a multicentric controlled study].
Lang E; Fitscha P; Schiess W
Wien Med Wochenschr; 1979 Sep; 129(17):484-8. PubMed ID: 120078
[TBL] [Abstract][Full Text] [Related]
6. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
Antalóczy Z; Kekes E
Zhongguo Yao Li Xue Bao; 1989 May; 10(3):222-6. PubMed ID: 2609991
[TBL] [Abstract][Full Text] [Related]
7. A double blind study of Visken LB-46, in the treatment of angina pectoris.
Nair DV
Indian Heart J; 1972 Jun; 24():Suppl 1:183-91. PubMed ID: 4581426
[No Abstract] [Full Text] [Related]
8. Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia.
Cocco G; Strozzi C; Chu D; Amrein R; Castagnoli E
Eur J Cardiol; 1979 Jul; 10(1):59-69. PubMed ID: 111940
[TBL] [Abstract][Full Text] [Related]
9. [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris].
Bonelli J; Gazo F; Liedtke RK
Arzneimittelforschung; 1989 Nov; 39(11A):1515-7. PubMed ID: 2576203
[TBL] [Abstract][Full Text] [Related]
10. Comparison of slow-release pindolol, standard pindolol, and propranolol in angina pectoris.
Parker JO
Am J Cardiol; 1983 Apr; 51(7):1062-6. PubMed ID: 6404149
[TBL] [Abstract][Full Text] [Related]
11. Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol.
Quyyumi AA; Wright C; Mockus L; Fox KM
Br Med J (Clin Res Ed); 1984 Oct; 289(6450):951-3. PubMed ID: 6148991
[TBL] [Abstract][Full Text] [Related]
12. Propranolol and LB 46 (prinodolol) in angina pectoris. A comparative long-term ergometric study.
Arstila M; Kallio V; Wendelin H
Ann Clin Res; 1973 Apr; 5(2):91-100. PubMed ID: 4201295
[No Abstract] [Full Text] [Related]
13. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
[TBL] [Abstract][Full Text] [Related]
14. The effect of timolol vs placebo on angina pectoris.
Aronow WS; Turbow M; Van Camp S; Lurie M; Whittaker K
Circulation; 1980 Jan; 61(1):66-9. PubMed ID: 6765920
[TBL] [Abstract][Full Text] [Related]
15. A double blind drug trial of LB-46 (visken) in angina pectoris.
Sainani GS; Mukherjee AK
Indian Heart J; 1972 Jun; 24():Suppl 1:192-6. PubMed ID: 4581427
[No Abstract] [Full Text] [Related]
16. Sustained effects of nitroglycerin ointment in patients with angina pectoris.
Reichek N; Goldstein RE; Redwood DR; Epstein SE
Circulation; 1974 Aug; 50(2):348-52. PubMed ID: 4211087
[No Abstract] [Full Text] [Related]
17. A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial).
Srivastava BN; Jain PC; Vyas GP
Indian Heart J; 1972 Jun; 24():Suppl 1:203-4. PubMed ID: 4581428
[No Abstract] [Full Text] [Related]
18. Verapamil in chronic stable angina: a controlled study with computerized multistage treadmill exercise.
Bala Subramanian V; Lahiri A; Parmasivan R; Raftery EB
Clin Invest Med; 1980; 3(1-2):111-8. PubMed ID: 6781805
[No Abstract] [Full Text] [Related]
19. LB-46 in angina pectoris. A critique of anti-anginal drug assessment.
Ganeshan KP; Xavier KB
Indian Heart J; 1972 Jun; 24():Suppl 1:197-20. PubMed ID: 4147275
[No Abstract] [Full Text] [Related]
20. Treatment of coexistent angina pectoris and hypertension with prindolol.
Leary WP; Asmal AC
S Afr Med J; 1975 Jan; 49(1):11-2. PubMed ID: 803324
[No Abstract] [Full Text] [Related]
[Next] [New Search]
